Cargando…

Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232

BACKGROUND: Mycoplasma hyopneumoniae causes respiratory disease in swine and contributes to the porcine respiratory disease complex, a major disease problem in the swine industry. The M. hyopneumoniae strain 232 genome is one of the smallest and best annotated microbial genomes, containing only 728...

Descripción completa

Detalles Bibliográficos
Autores principales: Pendarvis, Ken, Padula, Matthew P, Tacchi, Jessica L, Petersen, Andrew C, Djordjevic, Steven P, Burgess, Shane C, Minion, F Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102725/
https://www.ncbi.nlm.nih.gov/pubmed/25005615
http://dx.doi.org/10.1186/1471-2164-15-576
_version_ 1782327050151919616
author Pendarvis, Ken
Padula, Matthew P
Tacchi, Jessica L
Petersen, Andrew C
Djordjevic, Steven P
Burgess, Shane C
Minion, F Chris
author_facet Pendarvis, Ken
Padula, Matthew P
Tacchi, Jessica L
Petersen, Andrew C
Djordjevic, Steven P
Burgess, Shane C
Minion, F Chris
author_sort Pendarvis, Ken
collection PubMed
description BACKGROUND: Mycoplasma hyopneumoniae causes respiratory disease in swine and contributes to the porcine respiratory disease complex, a major disease problem in the swine industry. The M. hyopneumoniae strain 232 genome is one of the smallest and best annotated microbial genomes, containing only 728 annotated genes and 691 known proteins. Standard protein databases for mass spectrometry only allow for the identification of known and predicted proteins, which if incorrect can limit our understanding of the biological processes at work. Proteogenomic mapping is a methodology which allows the entire 6-frame genome translation of an organism to be used as a mass spectrometry database to help identify unknown proteins as well as correct and confirm existing annotations. This methodology will be employed to perform an in-depth analysis of the M. hyopneumoniae proteome. RESULTS: Proteomic analysis indicates 483 of 691 (70%) known M. hyopneumoniae strain 232 proteins are expressed under the culture conditions given in this study. Furthermore, 171 of 328 (52%) hypothetical proteins have been confirmed. Proteogenomic mapping resulted in the identification of previously unannotated genes gatC and rpmF and 5-prime extensions to genes mhp063, mhp073, and mhp451, all conserved and annotated in other M. hyopneumoniae strains and Mycoplasma species. Gene prediction with Prodigal, a prokaryotic gene predicting program, completely supports the new genomic coordinates calculated using proteogenomic mapping. CONCLUSIONS: Proteogenomic mapping showed that the protein coding genes of the M. hyopneumoniae strain 232 identified in this study are well annotated. Only 1.8% of mapped peptides did not correspond to genes defined by the current genome annotation. This study also illustrates how proteogenomic mapping can be an important tool to help confirm, correct and append known gene models when using a genome sequence as search space for peptide mass spectra. Using a gene prediction program which scans for a wide variety of promoters can help ensure genes are accurately predicted or not missed completely. Furthermore, protein extraction using differential detergent fractionation effectively increases the number of membrane and cytoplasmic proteins identifiable my mass spectrometry. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-576) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4102725
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41027252014-09-19 Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232 Pendarvis, Ken Padula, Matthew P Tacchi, Jessica L Petersen, Andrew C Djordjevic, Steven P Burgess, Shane C Minion, F Chris BMC Genomics Research Article BACKGROUND: Mycoplasma hyopneumoniae causes respiratory disease in swine and contributes to the porcine respiratory disease complex, a major disease problem in the swine industry. The M. hyopneumoniae strain 232 genome is one of the smallest and best annotated microbial genomes, containing only 728 annotated genes and 691 known proteins. Standard protein databases for mass spectrometry only allow for the identification of known and predicted proteins, which if incorrect can limit our understanding of the biological processes at work. Proteogenomic mapping is a methodology which allows the entire 6-frame genome translation of an organism to be used as a mass spectrometry database to help identify unknown proteins as well as correct and confirm existing annotations. This methodology will be employed to perform an in-depth analysis of the M. hyopneumoniae proteome. RESULTS: Proteomic analysis indicates 483 of 691 (70%) known M. hyopneumoniae strain 232 proteins are expressed under the culture conditions given in this study. Furthermore, 171 of 328 (52%) hypothetical proteins have been confirmed. Proteogenomic mapping resulted in the identification of previously unannotated genes gatC and rpmF and 5-prime extensions to genes mhp063, mhp073, and mhp451, all conserved and annotated in other M. hyopneumoniae strains and Mycoplasma species. Gene prediction with Prodigal, a prokaryotic gene predicting program, completely supports the new genomic coordinates calculated using proteogenomic mapping. CONCLUSIONS: Proteogenomic mapping showed that the protein coding genes of the M. hyopneumoniae strain 232 identified in this study are well annotated. Only 1.8% of mapped peptides did not correspond to genes defined by the current genome annotation. This study also illustrates how proteogenomic mapping can be an important tool to help confirm, correct and append known gene models when using a genome sequence as search space for peptide mass spectra. Using a gene prediction program which scans for a wide variety of promoters can help ensure genes are accurately predicted or not missed completely. Furthermore, protein extraction using differential detergent fractionation effectively increases the number of membrane and cytoplasmic proteins identifiable my mass spectrometry. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-576) contains supplementary material, which is available to authorized users. BioMed Central 2014-07-08 /pmc/articles/PMC4102725/ /pubmed/25005615 http://dx.doi.org/10.1186/1471-2164-15-576 Text en © Pendarvis et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pendarvis, Ken
Padula, Matthew P
Tacchi, Jessica L
Petersen, Andrew C
Djordjevic, Steven P
Burgess, Shane C
Minion, F Chris
Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
title Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
title_full Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
title_fullStr Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
title_full_unstemmed Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
title_short Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
title_sort proteogenomic mapping of mycoplasma hyopneumoniae virulent strain 232
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102725/
https://www.ncbi.nlm.nih.gov/pubmed/25005615
http://dx.doi.org/10.1186/1471-2164-15-576
work_keys_str_mv AT pendarvisken proteogenomicmappingofmycoplasmahyopneumoniaevirulentstrain232
AT padulamatthewp proteogenomicmappingofmycoplasmahyopneumoniaevirulentstrain232
AT tacchijessical proteogenomicmappingofmycoplasmahyopneumoniaevirulentstrain232
AT petersenandrewc proteogenomicmappingofmycoplasmahyopneumoniaevirulentstrain232
AT djordjevicstevenp proteogenomicmappingofmycoplasmahyopneumoniaevirulentstrain232
AT burgessshanec proteogenomicmappingofmycoplasmahyopneumoniaevirulentstrain232
AT minionfchris proteogenomicmappingofmycoplasmahyopneumoniaevirulentstrain232